The main objective is to replicate the validation of omics biomarkers of left ventricular diastolic dysfunction in patients with metabolic syndrome. The aim was to recruit overall 750 patients in Europe (100 for France). Currently, 625 patients were enrolled in Europe and 47 in France.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
47
Cardiovascular Hospitalizations or Cardiovascular Death
Time frame: 12 months
Cardiovascular Hospitalizations
Time frame: 3 months, 6 months, 12 months
Heart Failure Hospitalizations
Time frame: 3 months, 6 months, 12 months
Other cardiovascular hospitalizations
Time frame: 3 months, 6 months, 12 months
Non cardiovascular hospitalizations
Time frame: 3 months, 6 months, 12 months
Cardiovascular Death
Time frame: 3 months, 6 months, 12 months
Non cardiovascular Death
Time frame: 3 months, 6 months, 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.